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The goal of this work was to develop fast and selective method for the determination 
of maraviroc in human placental perfusions. The ultra-high performance liquid 
chromatography with tandem mass spectrometry (UHPLC-MS/MS) was used. BEH C18 
column and gradient elution with the mobile phase A (water with 0.1% formic acid) 
and B (acetonitrile) at 0.35 mL/min flow-rate and 40 °C temperature were used for the 
separation. The mass spectrometry conditions were optimist and set up as follows: 
electrospray ionization in positive mode, capillary voltage 1.0 kV, cone voltage 35 V, 
extractor 3.0 V, RF lens 0.1 V, desolvatation gas flow 1000 L/h, temperature 450 ºC, 
cone gas flow 100 l/h, ion source temperature 130 ºC. Selected reaction monitoring 
(SRM) mode was used for quantitation. Liquid-liquid extraction (LLE) was chosen for 
sample preparation and was optimised. The best results were obtained when 
dichloromethane was used as the extraction agent (recovery >90%). The optimized 
method was fully validated in the range 1-1000 ng/mL at five concentration levels (1 
ng/mL, 2.5 ng/mL, 50 ng/mL, 500 ng/mL and 1000 ng/mL) with the lower limit of 
quantification (LLOQ) 1 ng/mL and limit of detection (LOD) 0.3 ng/mL. Precision (RSD 
%) and accuracy (% bias) was determined for each concentration level: 1 ng/mL (RSD = 
8.1%, bias = +17.5%), 2.5 ng/mL (RSD = 13.0%, bias = +13.5% ), 50 ng/mL (RSD = 2.6%, 
bias = +3.3%), 500 ng/mL (RSD = 2.7%, bias = +0.4%), 1000 ng/mL (RSD = 1.7%, bias = -
0.6%). Further parameters of validation were linearity (R2 = 0.9983) and matrix effects 
(99.1% - 109.2%) at four concentration levels: 1 ng/mL, 50 ng/mL, 500 ng/mL and 1000 
ng/mL. The stable isotopically labelled internal standard d6-maraviroc, was used for 
quantification in all experiments. The method enabled sensitive and selective 
determination of maraviroc in placental perfusions.  
